| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,251 |
3,671 |
$262K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,805 |
3,293 |
$156K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,096 |
979 |
$134K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,855 |
1,663 |
$87K |
| 99215 |
Prolong outpt/office vis |
732 |
586 |
$61K |
| 96160 |
|
2,194 |
2,004 |
$37K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,374 |
1,273 |
$37K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
537 |
503 |
$35K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
545 |
462 |
$32K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
317 |
294 |
$22K |
| 96127 |
|
2,493 |
2,178 |
$12K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
775 |
711 |
$12K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
146 |
133 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
320 |
308 |
$10K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
237 |
217 |
$6K |
| 92551 |
|
580 |
539 |
$4K |
| 69210 |
|
76 |
64 |
$3K |
| 99177 |
|
253 |
235 |
$2K |
| 99173 |
|
314 |
295 |
$2K |
| D1206 |
Topical application of fluoride varnish |
67 |
67 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
108 |
107 |
$1K |
| 99401 |
|
51 |
32 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
61 |
37 |
$854.44 |
| D0190 |
|
67 |
67 |
$768.00 |
| 90686 |
|
836 |
759 |
$721.95 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
15 |
13 |
$561.48 |
| 90734 |
|
27 |
25 |
$505.10 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
13 |
$488.35 |
| 90670 |
|
249 |
226 |
$482.76 |
| 85018 |
|
102 |
92 |
$238.97 |
| 0011A |
|
17 |
14 |
$220.22 |
| 92558 |
|
40 |
36 |
$203.20 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
21 |
19 |
$186.54 |
| 81003 |
|
94 |
79 |
$184.95 |
| 36415 |
Collection of venous blood by venipuncture |
65 |
62 |
$147.92 |
| 94760 |
|
610 |
533 |
$142.46 |
| 36416 |
|
70 |
64 |
$137.35 |
| 90723 |
|
80 |
69 |
$70.72 |
| 90648 |
|
260 |
237 |
$34.74 |
| 99072 |
|
3,219 |
2,634 |
$0.58 |
| 91301 |
|
17 |
14 |
$0.02 |
| 90651 |
|
13 |
12 |
$0.01 |
| 99000 |
|
1,439 |
1,253 |
$0.00 |
| 91307 |
|
14 |
14 |
$0.00 |
| 90681 |
|
20 |
13 |
$0.00 |